These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32760393)

  • 1. CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.
    Bogacka J; Ciapała K; Pawlik K; Kwiatkowski K; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Front Immunol; 2020; 11():1241. PubMed ID: 32760393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CCR4 Diminishes Hypersensitivity and Enhances Opioid Analgesia - Evidence from a Mouse Model of Diabetic Neuropathy.
    Bogacka J; Ciapała K; Pawlik K; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Neuroscience; 2020 Aug; 441():77-92. PubMed ID: 32592824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
    Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
    Front Immunol; 2021; 12():781310. PubMed ID: 34795678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
    Pawlik K; Piotrowska A; Kwiatkowski K; Ciapała K; Popiolek-Barczyk K; Makuch W; Mika J
    Immunology; 2020 Apr; 159(4):413-428. PubMed ID: 31919846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
    Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
    Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
    Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.
    Pilat D; Piotrowska A; Rojewska E; Jurga A; Ślusarczyk J; Makuch W; Basta-Kaim A; Przewlocka B; Mika J
    Mol Cell Neurosci; 2016 Mar; 71():114-24. PubMed ID: 26763728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model.
    Pilat D; Rojewska E; Jurga AM; Piotrowska A; Makuch W; Przewlocka B; Mika J
    Eur J Pharmacol; 2015 Oct; 764():240-248. PubMed ID: 26043968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
    Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Mika J
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):402-419. PubMed ID: 28337574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.
    Ciapała K; Rojewska E; Pawlik K; Ciechanowska A; Mika J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses.
    Kwiatkowski K; Ciapała K; Rojewska E; Makuch W; Mika J
    Int Immunopharmacol; 2020 Jul; 84():106540. PubMed ID: 32402949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model.
    Rojewska E; Piotrowska A; Jurga A; Makuch W; Mika J
    Eur J Pharmacol; 2018 Nov; 839():21-32. PubMed ID: 30213497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model.
    Rojewska E; Ciapała K; Mika J
    Pharmacol Rep; 2019 Feb; 71(1):139-148. PubMed ID: 30550994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats.
    Jurga AM; Piotrowska A; Starnowska J; Rojewska E; Makuch W; Mika J
    Pharmacol Rep; 2016 Feb; 68(1):206-13. PubMed ID: 26721375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
    Front Immunol; 2019; 10():2198. PubMed ID: 31616413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional opioid/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy.
    Starnowska J; Guillemyn K; Makuch W; Mika J; Ballet S; Przewlocka B
    Eur J Pharm Sci; 2017 Jun; 104():221-229. PubMed ID: 28347772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.